Eribulin for the Treatment of Locally Advanced or Metastatic Breast Cancer (TA250)

Trabectedin for the Treatment of Relapsed Ovarian Cancer (TA222)

Bevacizumab in Combination with a Taxane for the First-Line Treatment of Metastatic Breast Cancer (TA214)

Topotecan for the Treatment of Recurrent and Stage IVB Cervical Cancer (TA183)

Cancer, Breast (Early): Hormonal Therapies (NICE)

Cancer, Breast (Metastatic): Gemcitabine (NICE)

Cancer, Ovarian (Advanced): Paclitaxel, Pegylated Liposomal Doxorubicin and Topotecan (NICE)

Cancer, Ovarian: Paclitaxel (NICE)